• Top in endocrinology: ADA guideline updates, metformin recall

    17 days ago - By Healio

    The American Diabetes Association recently issued its 2022 Standards of Care, which includes recommendations for screening and first-line therapy. It was the top story in Endocrinology last week.
    Another top story was about a voluntary safety recall of metformin products. Viona Pharmaceuticals, Inc., announced that it withdrew 33 lots of metformin hydrochloride tablets due to the presence of N-Nitrosodimethylamine, or NDMA.
    Read these and more top stories in endocrinology below:
    First-line therapy, diabetes screening updates among changes in ADA 2022 Standards of Care
    Recommendations for
    Read more ...